§ 13F · FUND PROFILE
ARCH Venture Management, LLC.
AUM · $1.1B (13F)Positions · 12Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$319M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | PBLS | PARABILIS MEDICINES INC | 6.41M | $176M | 16.0% | NEW |
| 2 | BEAM | BEAM THERAPEUTICS INC | 4.54M | $156M | 14.2% | ±0% |
| 3 | RAPP | RAPPORT THERAPEUTICS INC | 3.73M | $155M | 14.1% | ±0% |
| 4 | SPTX | SEAPORT THERAPEUTICS INC | 6.29M | $137M | 12.4% | NEW |
| 5 | ERAS | ERASCA INC | 7.09M | $130M | 11.8% | ±0% |
| 6 | VIR | VIR BIOTECHNOLOGY INC | 12.69M | $129M | 11.8% | −2% |
| 7 | MAZE | MAZE THERAPEUTICS INC | 4.12M | $123M | 11.2% | ±0% |
| 8 | LYEL | LYELL IMMUNOPHARMA INC | 3.25M | $46M | 4.1% | ±0% |
| 9 | GENB | GENERATE BIOMEDICINES INC | 1.94M | $33M | 3.0% | ±0% |
| 10 | TXG | 10X GENOMICS INC | 218K | $8M | 0.8% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ARCH SIGNAL
AC read
ARCH Venture Management, LLC is a Other fund managing $1.1 billion in assets. The fund runs a focused portfolio of just 12 positions.
Read the full dossier →